339 related articles for article (PubMed ID: 7958493)
21. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
[TBL] [Abstract][Full Text] [Related]
22. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects.
Suter SL; Nolan JJ; Wallace P; Gumbiner B; Olefsky JM
Diabetes Care; 1992 Feb; 15(2):193-203. PubMed ID: 1547676
[TBL] [Abstract][Full Text] [Related]
23. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.
Vaag A; Henriksen JE; Madsbad S; Holm N; Beck-Nielsen H
J Clin Invest; 1995 Feb; 95(2):690-8. PubMed ID: 7860750
[TBL] [Abstract][Full Text] [Related]
24. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus.
Del Prato S; Bonadonna RC; Bonora E; Gulli G; Solini A; Shank M; DeFronzo RA
J Clin Invest; 1993 Feb; 91(2):484-94. PubMed ID: 8432857
[TBL] [Abstract][Full Text] [Related]
25. Thermic effect of glucose in obese subjects with non-insulin-dependent diabetes mellitus.
Ravussin E; Zawadzki JK
Diabetes; 1987 Dec; 36(12):1441-7. PubMed ID: 3315790
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
[TBL] [Abstract][Full Text] [Related]
27. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance.
Del Prato S; Matsuda M; Simonson DC; Groop LC; Sheehan P; Leonetti F; Bonadonna RC; DeFronzo RA
Diabetologia; 1997 Jun; 40(6):687-97. PubMed ID: 9222649
[TBL] [Abstract][Full Text] [Related]
28. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
Frias JP; Yu JG; Kruszynska YT; Olefsky JM
Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
[TBL] [Abstract][Full Text] [Related]
29. Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin.
Damsbo P; Hermann LS; Vaag A; Hother-Nielsen O; Beck-Nielsen H
Diabetes Care; 1998 Sep; 21(9):1489-94. PubMed ID: 9727896
[TBL] [Abstract][Full Text] [Related]
30. Glucose fluxes and oxidation after an oral glucose load in patients with non-insulin-dependent diabetes mellitus of variable severity.
Féry F; Melot C; Balasse EO
Metabolism; 1993 Apr; 42(4):522-30. PubMed ID: 8487677
[TBL] [Abstract][Full Text] [Related]
31. NIDDM in the elderly.
Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
[TBL] [Abstract][Full Text] [Related]
32. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
Mandarino LJ; Consoli A; Jain A; Kelley DE
Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694
[TBL] [Abstract][Full Text] [Related]
33. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?
Vaag A; Alford F; Beck-Nielsen H
Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456
[TBL] [Abstract][Full Text] [Related]
34. Preservation of glucose tolerance and insulin secretory response to repeated glucose levels by the feeding of minimal glucose during prolonged fasting.
Abraira C; Lawrence AM
Metabolism; 1981 Dec; 30(12):1200-8. PubMed ID: 7031419
[TBL] [Abstract][Full Text] [Related]
35. Impaired activation of skeletal muscle glycogen synthase in non-insulin-dependent diabetes mellitus is unrelated to the degree of obesity.
Johnson AB; Argyraki M; Thow JC; Jones IR; Broughton D; Miller M; Taylor R
Metabolism; 1991 Mar; 40(3):252-60. PubMed ID: 1900343
[TBL] [Abstract][Full Text] [Related]
36. Carbohydrate oxidation and storage in obese non-insulin-dependent diabetic patients. Effects of improving glycemic control.
Boden G; Ray TK; Smith RH; Owen OE
Diabetes; 1983 Nov; 32(11):982-7. PubMed ID: 6315513
[TBL] [Abstract][Full Text] [Related]
37. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.
Markovic TP; Jenkins AB; Campbell LV; Furler SM; Kraegen EW; Chisholm DJ
Diabetes Care; 1998 May; 21(5):687-94. PubMed ID: 9589225
[TBL] [Abstract][Full Text] [Related]
38. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.
Vauhkonen I; Niskanen L; Vanninen E; Kainulainen S; Uusitupa M; Laakso M
J Clin Invest; 1998 Jan; 101(1):86-96. PubMed ID: 9421470
[TBL] [Abstract][Full Text] [Related]
39. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus.
Kelley D; Mokan M; Veneman T
Metabolism; 1994 Dec; 43(12):1549-57. PubMed ID: 7990710
[TBL] [Abstract][Full Text] [Related]
40. Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients.
Piatti PM; Monti LD; Davis SN; Conti M; Brown MD; Pozza G; Alberti KG
Diabetologia; 1996 Jan; 39(1):103-12. PubMed ID: 8720610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
